Taking people in Lengyelország1. fázis
An open-label, multicentre, rollover study to evaluate safety and antineoplastic activity of OATD-02 in patients with selected advances and/or metastatic solid tumours who completed the first-in-human study OATD-02-C-01
Key facts
- Where
- Bydgoszcz, Otwock és Warsaw, LengyelországSee the 3 sites
- Phase
- 1. fázis
Where in Lengyelország
- Centrum Onkologii Im. Prof. Franciszka Lukaszczyka W BydgoszczyBydgoszcz, LengyelországTaking people
- Europejskie Centrum Zdrowia Otwock Sp. Z.o.o.Otwock, LengyelországTaking people
- LUX MED Onkologia Sp. z.o.o.Warsaw, LengyelországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Molecure S.A.
- Trial code
- EU 2024-513006-61-00
- Record updated
- 2026. február 19.